Li Y.-M.,Shenyang Pharmaceutical University |
Chen L.,Drug Market Compliance Office of State Food and Drug Administration |
Huang Z.-L.,Drug Market Compliance Office of State Food and Drug Administration |
Bai Y.-P.,Drug Market Compliance Office of State Food and Drug Administration |
And 2 more authors.
Chinese Journal of New Drugs | Year: 2012
Using method of comparative study, we introduced the development of FDA regulation for prescription drug advertising, the division, financial resource, types and main regulation aspects, as well as Bad Ad Program of FDA. Then we summarized the experience and lesson in order to provide references for improving the regulation mode of dug advertising in our country. These include the rational use of regulation resources for drug advertising, ensuring whether the drug advertising information is easy to understand, and improving the awareness of doctors and the public to drug advertising.